Sign Up
HB 1139 North Dakota House · 67th Legislative Assembly (2021-2022)

Relating to duration limits for opioid therapy and benzodiazepine; and to provide for application.

Bill status signed all 5 stages cleared
Introduction
Jan 2021
Committee Review
Mar 2021
House Passage
Jan 2021
Senate Passage
Mar 2021
Signed into Law
Apr 2021
Introduced Jan 8, 2021 Signed Apr 1, 2021
Floor votes

How they voted

This bill passed the Senate. No roll call record of that vote is available.
Full legislative history

Actions timeline

Total actions
15
Key actions
7
Committee
4
Apr 5, 2021
Introduced
Filed with Secretary Of State 04/01
legislature
Apr 1, 2021
Signed into law
Signed by Governor 03/31
executive
Mar 23, 2021
Upper · Passed
Second reading, passed, yeas 38 nays 8
upper
Mar 22, 2021
Upper · Passed
Reported back, do pass, place on calendar 5 1 0
upper
Mar 8, 2021
Upper · Passed
Committee Hearing 02:30
upper
Feb 15, 2021
Introduced
Introduced, first reading, referred Industry, Business and Labor Committee
upper
Jan 27, 2021
Lower · Passed
Second reading, passed, yeas 64 nays 26
lower
Jan 21, 2021
Lower · Passed
Reported back, do pass, place on calendar 12 1 1
lower
Jan 18, 2021
Lower · Passed
Committee Hearing 08:00
lower
Jan 8, 2021
Introduced
Introduced, first reading, referred Industry, Business and Labor Committee
lower
0 primary · 2 co-sponsors

Sponsors

No sponsor information available.